ACT Pharmasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-01-03
Share capital
5,000.00 PLN
Average employment (people)
4.5 (2025)
Registered address
ul. Wileńska 14/1c, 03-414 Warszawa, Poland
Electronic delivery address
AE:PL-92733-62082-TFUAU-22

Financials

Revenue history (in k)

From the notes

Profit allocationNo decision

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 275 days for 2021).

  • 202515/06/2026
  • 202415/07/2025
  • 202326/01/2025
  • 202216/04/2023
  • 202116/04/2023
  • 202029/12/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 82%
Division · Retail trade5,491 / 9,938
Top 55%
City · Warszawa19,378 / 57,092
Top 34%
Voivodeship · Mazowieckie27,063 / 77,295
Top 35%
Country · Poland107,697 / 298,580
Top 36%

Results vs industry

Revenue
This companyUSD 691.15kMedianUSD 1.92mAverageUSD 5.21m
Net profit
This companyUSD -119.49kMedianUSD 21.05kAverageUSD 87.01k
Operating costs
This companyUSD 805.30kMedianUSD 1.88mAverageUSD 5.05m
Assets
This companyUSD 242.77kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

ACT Pharma has been an NFZ healthcare provider since 2026. In 2026 it is performing 1 contract worth USD 162.07.

Type of careNFZ branchContractsValue in 2026
Pilot programmesmazowieckie1USD 162.07

Authorized Representatives

Tobiasz Bożydar Migdałage 36 – President of the Management Board

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-01-10.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $11,567.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$779
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$779
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$779

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Cosmedicasp. z o.o.
DR ZdrowieS.A.
MagmaxS.A.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

FAQ

Last updated: 2026-10-07